Skip to main content
RECOVER: Researching COVID to Enhance Recovery Home
En Español
Esta página web solamente está disponible en ingles en este momento. Apreciamos su paciencia mientras traducimos el contenido de nuestra página.

News and Events

Stay up-to-date about
RECOVER

News and Updates

Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.

RECOVER logo with announcement banner.
Announcement

NIH to share RECOVER-TLC updates during November 21 webinar

NIH leaders will discuss the current status of RECOVER-TLC, share information about potential Long COVID treatments to be tested in RECOVER-TLC clinical trials, and answer questions from the public.

Clinical Trial

43 Results

Filters

43 Results

Filters Applied:

RECOVER researchers publish pediatric study design

The journal PLOS ONE has published the full RECOVER study design for babies, children, adolescents, and young adults taking part in RECOVER studies.
Observational Tissue Pathology Adult Pediatric Pregnant Adult
Announcement

NIH to open Long COVID clinical trials to study sleep disturbances, exercise intolerance, and post-exertional malaise

RECOVER-ENERGIZE and RECOVER-SLEEP will test multiple treatments for sleep disturbances, difficulties exercising, and worsening Long COVID symptoms after physical, mental, or emotional activity.

Clinical Trial Adult
News Release

NIH RECOVER makes Long COVID research data easier to access

Deidentified data from thousands of adults with Long COVID are now available to researchers.
Observational Adult
News Release

NIH opens Long COVID trials to evaluate treatments for autonomic nervous system dysfunction

RECOVER-AUTONOMIC will test at least three treatments for symptoms such as fast heart rate, dizziness and fatigue.
Clinical Trial Adult
News Release

Leadership Q&A: NIH to bolster RECOVER Long COVID research efforts

Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.

Clinical Trial EHR Observational Pathobiology Tissue Pathology Adult Pediatric Pregnant Adult
Q&A

NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million

This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.

Clinical Trial EHR Observational Pathobiology Tissue Pathology Adult Pediatric Pregnant Adult
News Release

Now Available: Dataset for “Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection”

Authorized researchers may request access to the dataset, which contains more than 3.3 million de-identified data entries and a Data Dictionary.
Observational Adult
Announcement

Changes in the body provide clues for the development of Long COVID

A research team that includes RECOVER researchers found changes in the immune systems of people with Long COVID.
Pathobiology Adult
News Release

Media Inquiries

Are you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.

Back to Top